Celiac Disease Clinical Trial
Official title:
Assessment of Gluten-Free Availability in Elaborated Food Stores in Three Neighbourhoods of Buenos Aires City
NCT number | NCT02312349 |
Other study ID # | 1770 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | September 2011 |
Est. completion date | January 2013 |
Verified date | August 2019 |
Source | Hospital Italiano de Buenos Aires |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Celiac disease (CD) is a chronic autoimmune disorder in genetically susceptible individuals
characterized by inflammation of the small intestine due to gluten intolerance. This protein
is found in cereals such as wheat, barley and rye. In Argentina, oats are also considered a
toxic grain since are as highly contaminated as the previous three. For this reason, the
acronym TACC (Trigo, avena, cebada y centono: wheat, oats, barley and centono) is used for
their identification. An effective treatment for celiac disease consists in a gluten-free
diet (GFD). For most patients, a gluten-free intake results in a symptomatic and pathological
complete remission and decreases the risk of complications.
The overall prevalence of CD is around 1% in several Western countries. An Argentinian study
shows a 1.167 prevalence of CD in studied patients, being doubled for women than men. Another
study in a closed population of the Health Plan of Hospital Italiano de Bs As estimated a
prevalence of 0.22 CD diagnosis. In developed countries, for each diagnosed case there is an
average of 5-10 cases that have not been diagnosed yet.
CD patients and their families should be properly informed about GFD, since there are many
factors, voluntary and involuntary, which can affect the treatment. Even though a strict diet
is imperative, food handling awareness is equally important in order to prevent
cross-contamination and gluten intake hidden in certain products.
In recent years, several countries have shown an increasing interest in improving the supply
of gluten-free foods in supermarkets, food factories and restaurants. In turn, a British
study shows that chefs have less awareness about celiac disease than the overall population.
Another Canadian study, which assessed the quality of life of people with CD, revealed that
80% of them avoid eating in restaurants for fear of contamination, causing a decrease in
their social life.
In Argentina, there are associations that generate lists of marks and gluten-free products
allowing safe intake of processed foods, however, it is unknown the food supply suitable for
consumption for people with CD as well as the staff's knowledge in gluten-free food
preparation in restaurants, pubs, pizzerias and fast food places. U.S. has quality assurance
systems that certify good manufacturing practices and GFD handling in restaurants and selling
local foods, although its application is not mandatory. In our country, there is no such
certification, so food safety on restaurants can not be guaranteed.
Eating behaviors are influenced by the reality in which people live, including food
availability indoors and outdoors. The current lifestyle leads more and more people to make
meals away from home, so that the variety and quality of food sold in restaurants and other
stores conditions the consumption. Thus, the availability of "safe" foods in places where
people with CD carried some of their meals, help improve adherence to the GFD.
The aim of this study is to investigate gluten-free products' supply in elaborated food
stores in Buenos Aires City and to discover the level of information possessed by
manufacturers in the production of food.
Status | Completed |
Enrollment | 112 |
Est. completion date | January 2013 |
Est. primary completion date | January 2013 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Restaurants, bars, pizzerias and fast food outlets, located in the three selected districts. Exclusion Criteria: -Refusal by the owner or manager of local participation in the study. |
Country | Name | City | State |
---|---|---|---|
Argentina | Hospital Italiano de Buenos Aires | Ciudad Autonoma de Buenos Aires |
Lead Sponsor | Collaborator |
---|---|
Hospital Italiano de Buenos Aires | Universidad Isalud |
Argentina,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Gluten Free elaborated food | Percentage of any available elaborated food free of gluten in its preparation an components for each restaurant evaluated | At baseline | |
Secondary | Knowledge about Celiac Disease | Direct structure questionnaire about specific items related to knowledge about celiac disease directed to every person involved in storage, preparation or delivery of elaborated food | At baseline | |
Secondary | Appropriate preparation, delivery and storage of Gluten Free dishes | Direct evaluation by inspection of the complete process of storage, preparation or delivery of elaborated food in each restaurant to detect potential sources of gluten contamination | At baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04349904 -
Near-Focus NBI Classification of Villous Atrophy in Suspected Coeliac Disease: International Development and Validation
|
||
Recruiting |
NCT05581628 -
FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE
|
||
Completed |
NCT04593251 -
Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis
|
Phase 1 | |
Completed |
NCT05810441 -
Intestinal Transglutaminase Antibodies in Celiac Disease Diagnosis
|
||
Recruiting |
NCT05555446 -
Bovine Colostrum to Prevent Absorption of Gluten
|
Early Phase 1 | |
Completed |
NCT02754609 -
Hookworm Therapy for Coeliac Disease
|
Phase 1 | |
Terminated |
NCT01902368 -
Celiac Disease Screening
|
N/A | |
Completed |
NCT02472704 -
Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo
|
N/A | |
Completed |
NCT01172665 -
Celiac Disease Database
|
||
Completed |
NCT01100099 -
HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease
|
Phase 2/Phase 3 | |
Completed |
NCT00639444 -
Risk of Celiac Disease and Age at Gluten Introduction
|
N/A | |
Active, not recruiting |
NCT05425446 -
Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients
|
Phase 1 | |
Enrolling by invitation |
NCT02202681 -
Imaging the Duodenum Using an Optical Frequency Domain Imaging OFDI Capsule
|
N/A | |
Completed |
NCT00362856 -
Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects
|
Phase 2 | |
Terminated |
NCT03866538 -
Budesonide in Patients With Immune Mediated Enteropathies
|
Phase 4 | |
Recruiting |
NCT05135923 -
Glutenfree, Gut Microbiota and Metabolic Regulation
|
N/A | |
Completed |
NCT05052164 -
Improvement Of Physical And Physiological Parameters In Menopausal Or Post-Menopausal Celiac Women
|
N/A | |
Completed |
NCT03775499 -
Probiotic BL NCC 2705 and Gluten Sensitivity
|
N/A | |
Completed |
NCT03707730 -
A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease
|
Phase 2 | |
Recruiting |
NCT05635266 -
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
|